Chronic rhinosinusitis: pathogenesis, therapy options, and more.
Umut Can KucuksezerCevdet ÖzdemirMübeccel AkdişMübeccel AkdisPublished in: Expert opinion on pharmacotherapy (2018)
Basic research in the last decade has helped significantly in enhancing our knowledge of the pathophysiologic processes of CRS, due to which there is now a better understanding of the associated natural history, physiopathology, novel treatments, and prevention strategies. Treatment success depends on the clarification of the underlying pathogenesis and disease-contributing factors. The exploration of disease endotypes and introduction of novel agents are important advancements. Prior studies performed without disease-endotyping resulted in the inefficiency of certain drugs and insignificant results. The identification of biomarkers, development of personalized approaches, and utilization of disease algorithms are required for CRS therapy success.